December 21 (SeeNews) - Bulgarian drug trader Sopharma Trading [BUL:SO5] said on Friday that its profit before taxes rose by an annual 19% to 17.4 million levs ($10.2 million/8.9 million euro) in the first eleven months of 2018, following an increase in revenue.
Sopharma Trading's sales added 8% year-on-year to 655.4 million levs in the January-November period, the company said in a bourse filing.
In November alone, the drug trader posted a pre-tax profit of 1.6 million levs, which compares to 1.9 million levs in November last year, reported previously by the company.
The drug trader's revenue in November grew 6% year-on-year to 64.8 million levs.
Sopharma Trading is a unit of Bulgarian drug maker Sopharma [BUL:3JR].
(1 euro = 1.95583 levs)